Location of immunization and interferon-γ are central to induction of salivary gland dysfunction in Ro60 peptide immunized model of Sjögren's syndrome

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  Yin, Hongen ^a   Vosters, Jelle L ^a,b   Roescher, Nienke ^a,b   D'Souza, Anil ^c   Kurien, Biji T ^c   Tak, Paul P ^b   Chiorini, John A ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; LA ANTIBODY; PEPTIDE; PERTUSSIS TOXIN; PROTEIN ANTIBODY; RO60 ANTIBODY; RO60 PEPTIDE; UNCLASSIFIED DRUG; AUTOANTIBODY; IMMUNOLOGICAL ADJUVANT; RIBONUCLEOPROTEIN; SS A ANTIGEN; SS-A ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; BAGG ALBINO MOUSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ACTIVITY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; IMMUNIZATION; LYMPHATIC DRAINAGE; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; SALIVARY GLAND DISEASE; SJOEGREN SYNDROME; SWISS JAMES LAMBERT MOUSE; ANIMAL; BIOSYNTHESIS; DISEASE MODEL; IMMUNOLOGY; INJECTION; LYMPHOCYTE ACTIVATION; PATHOLOGY; PATHOPHYSIOLOGY; SALIVARY GLAND; SALIVATION; SPLEEN; TH1 CELL;

MUS;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; AUTOANTIBODIES; DISEASE MODELS, ANIMAL; FEMALE; IMMUNIZATION; INJECTIONS; INTERFERON-GAMMA; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; RIBONUCLEOPROTEINS; SALIVARY GLANDS; SALIVATION; SJOGREN'S SYNDROME; SPLEEN; TH1 CELLS;

EID: 79953160463     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018003     Document Type: Article

References (22)

1. Harley JB, Scofield RH, Reichlin M, (1992) Anti-Ro in Sjogren's syndrome and systemic lupus erythematosus. Rheum Dis Clin North Am 18: 337-358.
2. Hansen A, Lipsky PE, Dorner T, (2003) New concepts in the pathogenesis of Sjogren syndrome: many questions, fewer answers. Curr Opin Rheumatol 15: 563-570.
3. Lodde BM, Mineshiba F, Kok MR, Wang J, Zheng C, et al. (2006) NOD mouse model for Sjogren's syndrome: lack of longitudinal stability. Oral Dis 12: 566-572.
4. Vosters JL, Landek-Salgado MA, Yin H, Swaim WD, Kimura H, et al. (2009) Interleukin-12 induces salivary gland dysfunction in transgenic mice, providing a new model of Sjogren's syndrome. Arthritis Rheum 60: 3633-3641.
5. Scofield RH, Asfa S, Obeso D, Jonsson R, Kurien BT, (2005) Immunization with short peptides from the 60-kDa Ro antigen recapitulates the serological and pathological findings as well as the salivary gland dysfunction of Sjogren's syndrome. J Immunol 175: 8409-8414.
6. Bombardieri M, Barone F, Pittoni V, Alessandri C, Conigliaro P, et al. (2004) Increased circulating levels and salivary gland expression of interleukin-18 in patients with Sjogren's syndrome: relationship with autoantibody production and lymphoid organization of the periductal inflammatory infiltrate. Arthritis Res Ther 6: R447-456.
7. Meehan S, Wu AJ, Kang EC, Sakai T, Ambudkar IS, (1997) Interferon-gamma induces a decrease in the intracellular calcium pump in a human salivary gland cell line. Am J Physiol 273: C2030-2036.
8. Wu AJ, Chen ZJ, Kan EC, Baum BJ, (1997) Interferon-gamma-induced JAK2 and STAT1 signalling in a human salivary gland cell line. J Cell Physiol 173: 110-114.
9. Papenfuss TL, Rogers CJ, Gienapp I, Yurrita M, McClain M, et al. (2004) Sex differences in experimental autoimmune encephalomyelitis in multiple murine strains. J Neuroimmunol 150: 59-69.
10. Sasaki M, Allina J, Odin JA, Thung SN, Coppel R, et al. (2002) Autoimmune cholangitis in the SJL/J mouse is antigen non-specific. Dev Immunol 9: 103-111.
11. Silver PB, Chan CC, Wiggert B, Caspi RR, (1999) The requirement for pertussis to induce EAU is strain-dependent: B10.RIII, but not B10.A mice, develop EAU and Th1 responses to IRBP without pertussis treatment. Invest Ophthalmol Vis Sci 40: 2898-2905.
12. Cruz LJ, Iglesias E, Aguilar JC, Gonzalez LJ, Reyes O, et al. (2004) A comparative study of different presentation strategies for an HIV peptide immunogen. Bioconjug Chem 15: 112-120.
13. Oscherwitz J, Yu F, Cease KB, (2009) A heterologous helper T-cell epitope enhances the immunogenicity of a multiple-antigenic-peptide vaccine targeting the cryptic loop-neutralizing determinant of Bacillus anthracis protective antigen. Infect Immun 77: 5509-5518.
14. Scofield RH, Kaufman KM, Baber U, James JA, Harley JB, et al. (1999) Immunization of mice with human 60-kd Ro peptides results in epitope spreading if the peptides are highly homologous between human and mouse. Arthritis Rheum 42: 1017-1024.
15. Abelson AK, Delgado-Vega AM, Kozyrev SV, Sanchez E, Velazquez-Cruz R, et al. (2009) STAT4 associates with systemic lupus erythematosus through two independent effects that correlate with gene expression and act additively with IRF5 to increase risk. Ann Rheum Dis 68: 1746-1753.
16. Rhodes DA, Ihrke G, Reinicke AT, Malcherek G, Towey M, et al. (2002) The 52 000 MW Ro/SS-A autoantigen in Sjogren's syndrome/systemic lupus erythematosus (Ro52) is an interferon-gamma inducible tripartite motif protein associated with membrane proximal structures. Immunology 106: 246-256.
17. Praprotnik S, Bozic B, Kveder T, Rozman B, (1999) Fluctuation of anti-Ro/SS-A antibody levels in patients with systemic lupus erythematosus and Sjogren's syndrome: a prospective study. Clin Exp Rheumatol 17: 63-68.
18. James JA, Gross T, Scofield RH, Harley JB, (1995) Immunoglobulin epitope spreading and autoimmune disease after peptide immunization: Sm B/B'-derived PPPGMRPP and PPPGIRGP induce spliceosome autoimmunity. J Exp Med 181: 453-461.
19. Pastor S, Minguela A, Mi W, Ward ES, (2009) Autoantigen immunization at different sites reveals a role for anti-inflammatory effects of IFN-gamma in regulating susceptibility to experimental autoimmune encephalomyelitis. J Immunol 182: 5268-5275.
20. Fox RI, (2005) Sjogren's syndrome. Lancet 366: 321-331.
21. Scofield RH, Henry WE, Kurien BT, James JA, Harley JB, (1996) Immunization with short peptides from the sequence of the systemic lupus erythematosus-associated 60-kDa Ro autoantigen results in anti-Ro ribonucleoprotein autoimmunity. J Immunol 156: 4059-4066.
22. Vivino FB, Gala I, Hermann GA, (2002) Change in final diagnosis on second evaluation of labial minor salivary gland biopsies. J Rheumatol 29: 938-944.